Investment Range
~$50M – $300M USD (est.)Estimated — modeled from this fund's AUM or comparable lenders, not confirmed by the fund. Counts for less than a confirmed range in match scoring.
Deal Types
Other, Senior
Sectors
Healthcare
Geographies
Global
AUM
—
Headquarters
—
Specialty-alt royalty finance (IN). Public Nasdaq RPRX; world's largest buyer of biopharmaceutical royalties and funder of life-sciences innovation. Royalty purchase / funding specialty — not classic senior credit.
This fund is handled through a TerraNova banker engagement — not a self-serve intro fee.
Banker engagement
Contacting Royalty Pharma through TerraNova is an advisory path — materials, diligence readiness, and process — not a low-fee self-serve intro.
Talk to a Banker →Investment Range
$25M – $200M USD
Investment Range
$5M – $25M USD
Investment Range
$10M – $50M USD
Match your deal against the full lender book — free to search.
Unlock full deal-team contacts
Reveal 4 deal-team contacts at Royalty Pharma — emails, LinkedIn, titles (permanent on your account).
Email bounces? Forward to deals@agentasllc.com — we re-credit within a business day. Unlock is private; your info is never sold. Sign in first — the unlock stays on your account.
Profile and contact information is compiled from public sources and TerraNova's own research. It is not provided or endorsed by the fund, and accuracy is not guaranteed.